The partners will particularly examine cell-free and exosomal RNAs as potential biomarkers for early-stage pancreatic cancer diagnosis in patients.
In PLOS this week: approach to diagnose hemorrhagic fevers, recessive disease mutations in mixed-breed dogs, and more.
Through prospective pancreatic ductal adenocarcinoma testing, researchers saw germline mutations in new genes and in cases outside of current germline testing criteria.
A new TGen analysis has unraveled breast cancer mutational patterns specific to black women that could help improve outcomes and reduce recurrence.
The partners aim to sequence thousands of tuberculosis bacteria isolates as part of a broader effort to develop personalized treatments for the disease.
Crowdfunding will help move the targeted sequencing-based test through the development process in hopes of commercializing it.
As part of the deal, TGen will also become a subsidiary of City of Hope's parent organization, but will remain a non-profit headquartered in Arizona.
The funds will support TGen's efforts to use graphics processing units to reduce single-cell transcriptome data analysis times from months to days.
By sequencing autopsy samples linked to an anthrax outbreak in 1979, investigators got a glimpse at Bacillus anthracis spores from a USSR production facility.
Dell plans to begin allowing clinical customers to store genomic datasets alongside patients' medical imaging data this spring.
A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.
Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.
A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.
In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more